SCHEDULE: Citadel Entities and Kenneth Griffin Disclose Significant Stake in Alignment Healthcare
Beneficial Ownership Disclosure
Citadel Advisors LLC, Citadel Securities LLC, and Kenneth Griffin have collectively disclosed beneficial ownership of 5.3% of Alignment Healthcare, Inc.'s common stock.
Summary
- Citadel Advisors LLC, Citadel Advisors Holdings LP, and Citadel GP LLC collectively beneficially own 9,352,976 shares of Alignment Healthcare, Inc., representing 4.7% of the outstanding common stock.
- Citadel Securities LLC, Citadel Securities Group LP, and Citadel Securities GP LLC collectively beneficially own 1,155,083 shares, representing 0.6% of the outstanding common stock.
- Kenneth Griffin, through his controlling interests in the Citadel entities, is deemed to beneficially own an aggregate of 10,508,059 shares, which constitutes 5.3% of Alignment Healthcare, Inc.'s common stock.
- The percentages are based on 197,843,352 shares outstanding as of April 28, 2025, according to the issuer's Form 10-Q filed on May 1, 2025.
- All reported share holdings for the reporting persons are as of the opening of the market on July 10, 2025.
Sentiment
Score: 6
Explanation: The disclosure of a significant passive stake by a prominent investment firm like Citadel and its founder Kenneth Griffin can be viewed positively by the market, suggesting institutional confidence in the company, even if it's a passive investment.
Future Outlook
This Schedule 13G filing is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance regarding the issuer's future performance or the reporting persons' future intentions beyond the certification that the securities were not acquired for the purpose of changing or influencing control.
Industry Context
The filing of a Schedule 13G indicates that an institutional investor or group has acquired beneficial ownership of more than 5% of a company's voting class of securities, but typically without the intent to control or influence the issuer. This type of filing is common for passive investment stakes by large asset managers or hedge funds like Citadel, signaling their position in the market.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake by Citadel and Kenneth Griffin may be perceived as a vote of confidence, potentially attracting other investors or stabilizing the stock price.
- Company Management: Awareness of a large institutional holder may influence management's strategic decisions, though the filing explicitly states the stake is not for control or influence.
Key Dates
| Date | Description |
|---|---|
| 2023-10-13 | Date a power of attorney for Kenneth Griffin was filed by Citadel Advisors LLC for Allakos Inc., which is incorporated by reference for this filing. |
| 2025-04-28 | Date as of which 197,843,352 shares of Alignment Healthcare, Inc. were outstanding, according to the issuer's Form 10-Q. |
| 2025-05-01 | Date Alignment Healthcare, Inc. filed its Form 10-Q with the SEC. |
| 2025-07-02 | Date of the event which required the filing of this Schedule 13G statement. |
| 2025-07-10 | Date the Schedule 13G was filed and the date as of which the reported share holdings are accurate. |
Keywords
Alignment Healthcare, Citadel, Kenneth Griffin, Schedule 13G, Beneficial Ownership, Institutional Investment, Healthcare, Common Stock, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.